Shelia M. Violette

Insider Reports History

Location
Waltham, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shelia M. Violette:

Company Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. Chief Scientific Officer Stock Option (Right to Buy) 56,413 $441,397 $13.42 24 Feb 2025 Direct
Q32 Bio Inc. Chief Scientific Officer Common Stock 58,384 $105,149 $1.80 26 Aug 2025 Direct
Q32 Bio Inc. Chief Scientific Officer Common Stock 36,277 $62,396 $1.72 26 Aug 2025 By Violette Holdings LLC

Insider Reports Filed by Shelia M. Violette

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QTTB Q32 Bio Inc. 26 Aug 2025 1 -$5,385 4 Chief Scientific Officer 28 Aug 2025, 19:28
QTTB Q32 Bio Inc. 24 Feb 2025 9 $0 4 Chief Scientific Officer 26 Feb 2025, 21:54
QTTB Q32 Bio Inc. 11 Oct 2024 5 +$58,011 4 Chief Scientific Officer 16 Oct 2024, 20:39
QTTB Q32 Bio Inc. 08 Oct 2024 2 +$41,496 4 Chief Scientific Officer 10 Oct 2024, 16:05
QTTB Homology Medicines, Inc. 25 Mar 2024 1 $0 4 Chief Scientific Officer 27 Mar 2024, 17:36
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 Chief Scientific Officer 27 Mar 2024, 17:32